Literature DB >> 10631204

Pleural fluid pH as a predictor of pleurodesis failure: analysis of primary data.

J E Heffner1, P J Nietert, C Barbieri.   

Abstract

STUDY
OBJECTIVES: To determine the predictive accuracy of pH for identifying patients with malignant pleural effusions who will fail pleurodesis.
DESIGN: Analysis of published and unpublished individual patient-level data retrieved from a MEDLINE search and correspondence with primary investigators. STUDY SELECTION: Studies that reported pleural fluid pH values and outcomes of pleurodesis for patients with malignant pleural effusions. DATA COLLECTION AND ANALYSIS: Primary investigators supplied data for 433 patients. Receiver operating characteristic analysis and logistic regression estimated the predictive accuracy, decision thresholds, and value of pleural fluid pH compared with other clinical factors. The primary investigations were graded for study design.
RESULTS: Pleural fluid pH was the only independent predictor of pleurodesis failure (odds ratio, 4.46; 95% confidence interval [CI], 2.69 to 7.45; p < 0.0001) and had an area under the receiver operating characteristic curve (decision threshold, < or = 7.28) of 0.671 (95% CI, 0.624 to 0.715). The pH model fit the data well (p = 0.48) with the probability of pleurodesis failure increasing as pH decreased; specificity and negative predictive values for pleurodesis failure exceeded 90% and 80%, respectively, with a positive predictive value of 45.7% at pH values < or = 7.15. The primary studies had several important design limitations.
CONCLUSIONS: Using patient-level data, this study showed that pleural fluid pH has only modest predictive value for predicting symptomatic failure and should be used with caution, if at all, in selecting patients for pleurodesis. The limitations of the primary studies and low predictive accuracy should be considered when using pleural fluid pH for patient care.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10631204     DOI: 10.1378/chest.117.1.87

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

Review 1.  Switching off malignant pleural effusion formation-fantasy or future?

Authors:  Magda Spella; Anastasios D Giannou; Georgios T Stathopoulos
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

2.  Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.

Authors:  Carolyn M Dresler; Jemi Olak; James E Herndon; William G Richards; Ernest Scalzetti; Stewart B Fleishman; Kemp H Kernstine; Todd Demmy; David M Jablons; Leslie Kohman; Thomas M Daniel; George B Haasler; David J Sugarbaker
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

3.  Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.

Authors:  Susana Herrera Lara; Estrella Fernández-Fabrellas; Gustavo Juan Samper; Josefa Marco Buades; Rafael Andreu Lapiedra; Amparo Pinilla Moreno; María Morales Suárez-Varela
Journal:  Lung       Date:  2017-06-27       Impact factor: 2.584

Review 4.  Malignant pleural effusions: appropriate treatment approaches.

Authors:  Yener Aydin; Atila Turkyilmaz; Yavuz Selim Intepe; Atilla Eroglu
Journal:  Eurasian J Med       Date:  2009-12

5.  Sodium hydroxide as a sclerosing agent in patients with neoplastic pleural effusion non-candidates for VATS: results of a minimally invasive protocol.

Authors:  Micaela Raices; Matías E Czerwonko; Agustin Dietrich; Alejandro Da Lozzo; Enrique Beveraggi; David Smith
Journal:  Updates Surg       Date:  2017-08-31

6.  Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome.

Authors:  Huseyin Yildirim; Muzaffer Metintas; Güntülü Ak; Sinan Erginel; Fusun Alatas; Emel Kurt; Selma Metintas; Irfan Ucgun
Journal:  Lung       Date:  2007-10-19       Impact factor: 2.584

Review 7.  Management of Malignant Lung Entrapment, the Oncothorax.

Authors:  Roman Petrov; Charles Bakhos; Abbas E Abbas
Journal:  Thorac Surg Clin       Date:  2018-02       Impact factor: 1.750

8.  Clinical predictors of successful and earlier pleurodesis with a tunnelled pleural catheter in malignant pleural effusion: a cohort study.

Authors:  Pen Li; Alison Graver; Sarah Hosseini; Sunita Mulpuru; Lorraine Cake; Lynn Kachuik; Tinghua Zhang; Kayvan Amjadi
Journal:  CMAJ Open       Date:  2018-06-13

9.  Analysis of C-reactive protein and biochemical parameters in pericardial fluid.

Authors:  Turan Ege; Melih Hulusi Us; Mustafa Cikirikcioglu; Cavidan Arar; Enver Duran
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

10.  Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.

Authors:  Islam M Ibrahim; Ahmed L Dokhan; Alaa A El-Sessy; Mohammed F Eltaweel
Journal:  J Cardiothorac Surg       Date:  2015-05-01       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.